TC BioPharm
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1-2 Parklands Way, Motherwell, North Lan...Phone Number
+44 1414337557Website
www.tcbiopharm.comRevenue
$8.7 MillionStock Symbol
TCBPIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About TC BioPharm
TC BioPharm (Nasdaq: TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. Established in 2014, the company has expanded into 5 global locations and have grown to over 100 employees.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TC BioPharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if TC BioPharm had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when TC BioPharm launches new products
Funding: Get notified immidiatlly once TC BioPharm has new funding data
Check if TC BioPharm has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on TC BioPharm recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at TC BioPharm
Check out if TC BioPharm is spiking on competitors!
TC BioPharm, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to TC BioPharm
Compare insights from companies similar to TC BioPharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TC BioPharm
$8.7M
11-50
Public
$13.7M
2014
N/A
Company Profile Activity
Activity Insights
TC BioPharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TC BioPharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TC BioPharm.
TC BioPharm financials insights
Gather financial insights about TC BioPharm, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$660K
Private Equity
$1.4M
2017
Series A
$6.7M
Grant
$4.7M
2024
Grant
$250K
TC BioPharm Tech Stack
A closer look at the technologies used by TC BioPharm
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
TC BioPharm News & Media
TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells
EDINBURGH, Scotland, April 9, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (OTC: TCBPY) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced receipt of a...TCBP Announces Transition from Nasdaq to OTC Markets
EDINBURGH, Scotland, March 21, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that on...TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
The company is expected to reduce core operational burn by 55% when compared to 2024 EDINBURGH, Scotland, March 18, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic...TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum
EDINBURGH, Scotland , Feb. 20, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that its...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TC BioPharm
Sign Up For FreeTo access detailed company insights
TC BioPharm (Nasdaq: TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. Established in 2014, the company has expanded into 5 global locations and have grown... Read More
